Gain Therapeutics GANX
NASDAQ GANX
$2.01 +0.03 (+1.26%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Property, Plant & Equipment (Net) (2020 - 2026)

Gain Therapeutics (GANX) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Gain Therapeutics 85.97 Mn 85.97 Mn - 47,026.00

Historic Data

Download Data
DateValue
Jun 30, 2026 47,026.00
Jun 30, 2026 47,026.00
Mar 31, 2026 54,435.00
Mar 31, 2026 54,435.00
Dec 31, 2025 74,916.00
Dec 31, 2025 74,916.00
Sep 30, 2025 85,572.00
Sep 30, 2025 85,572.00
Jun 30, 2025 96,190.00
Jun 30, 2025 96,190.00
Mar 31, 2025 97,509.00
Mar 31, 2025 97,509.00
Dec 31, 2024 457,602.00
Dec 31, 2024 457,602.00
Sep 30, 2024 119,610.00
Sep 30, 2024 119,610.00
Jun 30, 2024 123,930.00
Jun 30, 2024 123,930.00
Mar 31, 2024 111,909.00
Mar 31, 2024 111,909.00